Phase II Genomics Study of Ixabepilone as Neoadjuvant Treatment for Breast Cancer
JOURNAL OF CLINICAL ONCOLOGY (2009)
期刊
JOURNAL OF CLINICAL ONCOLOGY
卷 27, 期 4, 页码 526-534出版社
LIPPINCOTT WILLIAMS & WILKINS
关键词
类别
资金
- Bristol-Myers Squibb
作者
我是这篇论文的作者
推荐
Safety and efficacy of HSP90 inhibitor ganetespib for neoadjuvant treatment of stage II/III breast cancer
Julie E. Lang, Andres Forero-Torres, Douglas Yee, Christina Yau, Denise Wolf, John Park, Barbara A. Parker, A. Jo Chien, Anne M. Wallace, Rashmi Murthy, Kathy S. Albain, Erin D. Ellis, Heather Beckwith, Barbara B. Haley, Anthony D. Elias, Judy C. Boughey, Rachel L. Yung, Claudine Isaacs, Amy S. Clark, Hyo S. Han, Rita Nanda, Qamar J. Khan, Kristen K. Edmiston, Erica Stringer-Reasor, Elissa Price, Bonnie Joe, Minetta C. Liu, Lamorna Brown-Swigart, Emanuel F. Petricoin, Julia D. Wulfkuhle, Meredith Buxton, Julia L. Clennell, Ashish Sanil, Scott Berry, Smita M. Asare, Amy Wilson, Gillian L. Hirst, Ruby Singhrao, Adam L. Asare, Jeffrey B. Matthews, Michelle Melisko, Jane Perlmutter, Hope S. Rugo, W. Fraser Symmans, Laura J. van't Veer, Nola M. Hylton, Angela M. DeMichele, Donald A. Berry, Laura J. Esserman
NPJ BREAST CANCER (2022)
Pegylated Liposomal Doxorubicin, Docetaxel, and Trastuzumab as Neoadjuvant Treatment for HER2-Positive Breast Cancer Patients: A Phase II and Biomarker Study
Haoqi Wang, Yuntao Li, Yixin Qi, Erbao Zhao, Xiangshun Kong, Chao Yang, Qiqi Yang, Chengyuan Zhang, Yueping Liu, Zhenchuan Song
FRONTIERS IN ONCOLOGY (2022)
A phase II study of palbociclib plus letrozole plus trastuzumab as neoadjuvant treatment for clinical stages II and III ER+ HER2+ breast cancer (PALTAN)
Foluso O. Ademuyiwa, Donald W. Northfelt, Tracey O'Connor, Ellis Levine, Jingqin Luo, Yu Tao, Jeremy Hoog, Marie L. Laury, Tracy Summa, Trish Hammerschmidt, Zhanfang Guo, Ashley Frith, Katherine Weilbaecher, Mateusz Opyrchal, Rebecca Aft, Katherine Clifton, Rama Suresh, Nusayba Bagegni, Ian S. Hagemann, Michael D. Iglesia, Cynthia X. Ma
NPJ BREAST CANCER (2023)
Post-Neoadjuvant Treatment Strategies in Breast Cancer
Christiane Matuschek, Danny Jazmati, Edwin Boelke, Balint Tamaskovics, Stefanie Corradini, Wilfried Budach, David Krug, Svjetlana Mohrmann, Eugen Ruckhaeberle, Tanja Fehm, Carolin Nestle Kraemling, Markus Dommach, Jan Haussmann
CANCERS (2022)
Neoadjuvant study of niraparib in patients with HER2-negative, BRCA-mutated, resectable breast cancer
Laura M. Spring, Hyo Han, Minetta C. Liu, Erika Hamilton, Hanna Irie, Cesar A. Santa-Maria, James Reeves, Peng Pan, Ming Shan, Yongqiang Tang, Julie R. Graham, Sebastien Hazard, Leif W. Ellisen, Steven J. Isakoff
NATURE CANCER (2022)
Phase II trial of delta-tocotrienol in neoadjuvant breast cancer with evaluation of treatment response using ctDNA
Ina Mathilde Kjaer, Soren Kahns, Signe Timm, Rikke Fredslund Andersen, Jonna Skov Madsen, Erik Hugger Jakobsen, Tomasz Piotr Tabor, Anders Jakobsen, Troels Bechmann
SCIENTIFIC REPORTS (2023)
The African Female Breast Cancer Epidemiology Study Protocol
Emmanuel R. Ezeome, King-David T. Yawe, Omobolaji Ayandipo, Olawale Badejo, Sally N. Adebamowo, Benerdin Achusi, Adeola Fowotade, Gabriel Ogun, Clement A. Adebamowo
FRONTIERS IN ONCOLOGY (2022)
Post-Neoadjuvant Treatment Strategies for Patients with Early Breast Cancer
Elisa Agostinetto, Flavia Jacobs, Veronique Debien, Alex De Caluwe, Catalin-Florin Pop, Xavier Catteau, Philippe Aftimos, Evandro de Azambuja, Laurence Buisseret
CANCERS (2022)
A phase II study of neoadjuvant atezolizumab and nab-paclitaxel in patients with anthracycline-resistant early-stage triple-negative breast cancer
Clinton Yam, Elizabeth A. Mittendorf, Haven R. Garber, Ryan Sun, Senthil Damodaran, Rashmi K. Murthy, David Ramirez, Meghan Karuturi, Rachel M. Layman, Nuhad Ibrahim, Gaiane M. Rauch, Beatriz E. Adrada, Rosalind P. Candelaria, Jason B. White, Elizabeth Ravenberg, Alyson Clayborn, Qing Qing Ding, W. Fraser Symmans, Sabitha Prabhakaran, Alastair M. Thompson, Vicente Valero, Debu Tripathy, Lei Huo, Stacy L. Moulder, Jennifer K. Litton
BREAST CANCER RESEARCH AND TREATMENT (2023)
Ixabepilone: Overview of Effectiveness, Safety, and Tolerability in Metastatic Breast Cancer
Nuhad K. Ibrahim
FRONTIERS IN ONCOLOGY (2021)
Effects of contrast-enhanced ultrasound treatment on neoadjuvant chemotherapy in breast cancer
Anne Rix, Marion Piepenbrock, Barbara Flege, Saskia von Stillfried, Patrick Koczera, Tatjana Opacic, Nina Simons, Peter Boor, Sven Thoroe-Boveleth, Roel Deckers, Jan-Niklas May, Twan Lammers, Georg Schmitz, Elmar Stickeler, Fabian Kiessling
THERANOSTICS (2021)
Breast-conserving surgery versus mastectomy for treatment of breast cancer after neoadjuvant chemotherapy
Yu-Chun Song, Zhou Huang, Hui Fang, Yu Tang, Hao Jing, Yong-Wen Song, Jing Jin, Yue-Ping Liu, Bo Chen, Yuan Tang, Shu-Nan Qi, Ning-Ning Lu, Ning Li, Ye-Xiong Li, Shu-Lian Wang
FRONTIERS IN ONCOLOGY (2023)
Neoadjuvant Concurrent Radiotherapy and Chemotherapy in Early Breast Cancer Patients: Long-Term Results of a Prospective Phase II Trial
Diane Jornet, Pierre Loap, Jean-Yves Pierga, Fatima Laki, Anne Vincent-Salomon, Youlia M. Kirova, Alain Fourquet
CANCERS (2021)
Neoadjuvant chemotherapy for stage II-III breast cancer: a single-center experience
Haidi Abd El Zaher, Hamada Fathy, Mohamed Abozeid, Mohammed Faisal
WORLD JOURNAL OF SURGICAL ONCOLOGY (2023)
Multicenter, single-arm, phase II trial of camrelizumab and chemotherapy as neoadjuvant treatment for locally advanced esophageal squamous cell carcinoma
Jun Liu, Yang Yang, Zhichao Liu, Xiaolong Fu, Xiaoyue Cai, Hongxuan Li, Li Zhu, Yan Shen, Hong Zhang, Yifeng Sun, Hezhong Chen, Bentong Yu, Renquan Zhang, Jinchen Shao, Ming Zhang, Zhigang Li
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2022)
HER2-Enriched Subtype and ERBB2 Expression in HER2-Positive Breast Cancer Treated with Dual HER2 Blockade
Aleix Prat, Tomas Pascual, Carmine De Angelis, Carolina Gutierrez, Antonio Llombart-Cussac, Tao Wang, Javier Cortes, Brent Rexer, Laia Pare, Andres Forero, Antonio C. Wolff, Serafin Morales, Barbara Adamo, Fara Braso-Maristany, Maria Vidal, Jamunarani Veeraraghavan, Ian Krop, Patricia Galvan, Anne C. Pavlick, Begona Bermejo, Miguel Izquierdo, Vanessa Rodrik-Outmezguine, Jorge S. Reis-Filho, Susan G. Hilsenbeck, Mafalda Oliveira, Maria Vittoria Dieci, Gaia Griguolo, Roberta Fasani, Paolo Nuciforo, Joel S. Parker, PierFranco Conte, Rachel Schiff, Valentina Guarneri, C. Kent Osborne, Mothaffar F. Rimawi
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2020)
Phase III Trial of Adjuvant Capecitabine After Standard Neo-/Adjuvant Chemotherapy in Patients With Early Triple-Negative Breast Cancer (GEICAM/2003-11_CIBOMA/2004-01)
Ana Lluch, Carlos H. Barrios, Laura Torrecillas, Manuel Ruiz-Borrego, Jose Bines, Jose Segalla, Angel Guerrero-Zotano, Jose A. Garcia-Saenz, Roberto Torres, Juan de la Haba, Elena Garcia-Martinez, Henry L. Gomez, Antonio Llombart, Javier Salvador Bofill, Jose M. Baena-Canada, Agusti Barnadas, Lourdes Calvo, Laura Perez-Michel, Manuel Ramos, Isaura Fernandez, Alvaro Rodriguez-Lescure, Jesus Cardenas, Jeferson Vinholes, Eduardo Martinez de Duenas, Maria J. Godes, Miguel A. Segui, Antonio Anton, Pilar Lopez-Alvarez, Jorge Moncayo, Gilberto Amorim, Esther Villar, Salvador Reyes, Carlos Sampaio, Bernardita Cardemil, Maria J. Escudero, Susana Bezares, Eva Carrasco, Miguel Martin, J. Corona, C. Jara, B. Cardemil, R. Toro, C. Pimentel, B. Hernando, E. Vicente, L. Zagame, M. Gil, L. Garcia Estevez, C. Rodriguez, M. A. de la Cruz, J. M. Tello, S. Campos, M. Lomas, D. Capdevile, M. Campos, M. Margeli, R. Andres, I Tusquets, A. Ballesteros, A. Guerrero, M. Arguello, J. L. Rodriguez, M. Munoz, J. Florian, S. Azevedo, R. Mondragon, J. Peralta, A. E. Palomo, L. J. Barajas, A. Arcusa, H. Carranza, C. Garcia, C. Umbria, Jose E. Ales, J. M. Lopez Vega, M. Romeo, J. Valero, J. L. Alonso, C. Mathias, F. Gutierrez, E. Adrover, P. Nunez, C. Mendiola, J. Cassinello, A. de la Huerta
JOURNAL OF CLINICAL ONCOLOGY (2020)
Everolimus plus exemestane in hormone-receptor-positive, HER2-negative locally advanced or metastatic breast cancer: incidence and time course of adverse events in the phase IIIb BALLET population
E. Ciruelos, G. Jerusalem, M. Martin, V. C. G. Tjan-Heijnen, P. Neven, J. Gavila, F. Montemurro, D. Generali, I. Lang, M. J. Martinez-Serrano, M. F. Perello, P. Conte
CLINICAL & TRANSLATIONAL ONCOLOGY (2020)
Capivasertib, an AKT Kinase Inhibitor, as Monotherapy or in Combination with Fulvestrant in Patients with AKT1E17K-Mutant, ER-Positive Metastatic Breast Cancer
Lillian M. Smyth, Kenji Tamura, Mafalda Oliveira, Eva M. Ciruelos, Ingrid A. Mayer, Marie-Paule Sablin, Laura Biganzoli, Helen J. Ambrose, Jack Ashton, Alan Barnicle, Des D. Cashell, Claire Corcoran, Elza C. de Bruin, Andrew Foxley, Joana Hauser, Justin P. O. Lindemann, Rhiannon Maudsley, Robert McEwen, Michele Moschetta, Martin Pass, Vicky Rowlands, Gaia Schiavon, Udai Banerji, Maurizio Scaltriti, Barry S. Taylor, Sarat Chandarlapaty, Jose Baselga, David M. Hyman
CLINICAL CANCER RESEARCH (2020)
Overall Survival of CDK4/6-Inhibitor-Based Treatments in Clinically Relevant Subgroups of Metastatic Breast Cancer: Systematic Review and Meta-Analysis
Francesco Schettini, Fabiola Giudici, Mario Giuliano, Massimo Cristofanilli, Grazia Arpino, Lucia Del Mastro, Fabio Puglisi, Sabino De Placido, Ida Paris, Pietro De Placido, Sergio Venturini, Michelino De Laurentis, PierFranco Conte, Dejan Juric, Antonio Llombart-Cussac, Lajos Pusztai, Aleix Prat, Guy Jerusalem, Angelo Di Leo, Daniele Generali
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2020)
Genomic and Transcriptomic Analyses of Breast Cancer Primaries and Matched Metastases in AURORA, the Breast International Group (BIG) Molecular Screening Initiative
Philippe Aftimos, Mafalda Oliveira, Alexandre Irrthum, Debora Fumagalli, Christos Sotiriou, Einav Nili Gal-Yam, Mark E. Robson, Justin Ndozeng, Angelo Di Leo, Eva M. Ciruelos, Evandro de Azambuja, Giuseppe Viale, Elsemieke D. Scheepers, Giuseppe Curigliano, Judith M. Bliss, Jorge S. Reis-Filho, Marco Colleoni, Marija Balic, Fatima Cardoso, Joan Albanell, Caroline Duhem, Sandrine Marreaud, Dario Romagnoli, Beatriz Rojas, Andrea Gombos, Hans Wildiers, Angel Guerrero-Zotano, Peter Hall, Andrea Bonetti, Karolina Fs Larsson, Martina Degiorgis, Silvia Khodaverdi, Richard Greil, Asgerdur Sverrisdottir, Marta Paoli, Ethel Seyll, Sibylle Loibl, Barbro Linderholm, Gabriele Zoppoli, Nancy E. Davidson, Oskar Th Johannsson, Philippe L. Bedard, Sherene Loi, Susan Knox, David A. Cameron, Nadia Harbeck, Maite Lasa Montoya, Mariana Brandao, Andrea Vingiani, Carmela Caballero, Florentine S. Hilbers, Lucy R. Yates, Matteo Benelli, David Venet, Martine J. Piccart
CANCER DISCOVERY (2021)
Clinical Significance of PIK3CA and ESR1 Mutations in Circulating Tumor DNA: Analysis from the MONARCH 2 Study of Abemaciclib plus Fulvestrant
Sara M. Tolaney, Masakazu Toi, Patrick Neven, Joohyuk Sohn, Eva-Maria Grischke, Antonio Llombart-Cussac, Hatem Soliman, Hong Wang, Sameera Wijayawardana, Valerie M. Jansen, Lacey M. Litchfield, George W. Sledge
CLINICAL CANCER RESEARCH (2022)
Characterization of plasma circulating small extracellular vesicles in patients with metastatic solid tumors and newly diagnosed brain metastasis
Alberto Carretero-Gonzalez, Marta Hergueta-Redondo, Sara Sanchez-Redondo, Pilar Ximenez-Embun, Luis Manso Sanchez, Eva Ciruelos Gil, Daniel Castellano, Guillermo de Velasco, Hector Peinado
ONCOIMMUNOLOGY (2022)
Accuracy and Limitations of Sentinel Lymph Node Biopsy after Neoadjuvant Chemotherapy in Breast Cancer Patients with Positive Nodes
Sofia Aragon-Sanchez, M. Reyes Oliver-Perez, Ainhoa Madariaga, M. Jose Tabuenca, Mario Martinez, Alberto Galindo, M. Luisa Arroyo, Marta Gallego, Marta Blanco, Eva M. Ciruelos-Gil
BREAST JOURNAL (2022)
Sacituzumab Govitecan in Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer
Hope S. Rugo, Aditya Bardia, Frederik Marme, Javier Cortes, Peter Schmid, Delphine Loirat, Olivier Tredan, Eva Ciruelos, Florence Dalenc, Patricia Gomez Pardo, Komal L. Jhaveri, Rosemary Delaney, Olivia Fu, Lanjia Lin, Wendy Verret, Sara M. Tolaney
JOURNAL OF CLINICAL ONCOLOGY (2022)
Adjuvant Endocrine Therapy in Premenopausal Breast Cancer: 12-Year Results From SOFT
Prudence A. Francis, Gini F. Fleming, Istvan Lang, Eva M. Ciruelos, Herve R. Bonnefoi, Meritxell Bellet, Antonio Bernardo, Miguel A. Climent, Silvana Martino, Begona Bermejo, Harold J. Burstein, Nancy E. Davidson, Charles E. Geyer, Barbara A. Walley, James N. Ingle, Robert E. Coleman, Bettina Muller, Fanny Le Du, Sibylle Loibl, Eric P. Winer, Barbara Ruepp, Sherene Loi, Marco Colleoni, Alan S. Coates, Richard D. Gelber, Aron Goldhirsch, Meredith M. Regan
JOURNAL OF CLINICAL ONCOLOGY (2023)
Adjuvant Exemestane With Ovarian Suppression in Premenopausal Breast Cancer: Long-Term Follow-Up of the Combined TEXT and SOFT Trials
Olivia Pagani, Barbara A. Walley, Gini F. Fleming, Marco Colleoni, Istvan Lang, Henry L. Gomez, Carlo Tondini, Harold J. Burstein, Matthew P. Goetz, Eva M. Ciruelos, Vered Stearns, Herve R. Bonnefoi, Silvana Martino, Charles E. Geyer, Claudio Chini, Fabio Puglisi, Simon Spazzapan, Thomas Ruhstaller, Eric P. Winer, Barbara Ruepp, Sherene Loi, Alan S. Coates, Richard D. Gelber, Aron Goldhirsch, Meredith M. Regan, Prudence A. Francis
JOURNAL OF CLINICAL ONCOLOGY (2023)
CCNE1 and PLK1 Mediate Resistance to Palbociclib in HR+/HER2-Metastatic Breast Cancer
Angel Guerrero-Zotano, Stefania Belli, Christoph Zielinski, Miguel Gil-Gil, Antonio Fernandez-Serra, Manuel Ruiz-Borrego, Eva Maria Ciruelos Gil, Javier Pascual, Montserrat Munoz-Mateu, Begon Bermejo, Mireia Margeli Vila, Antonio Anton, Laura Murillo, Bella Nissenbaum, Yuan Liu, Jesus Herranz, Daniel Fernandez-Garcia, Rosalia Caballero, Jose Antonio Lopez-Guerrero, Roberto Bianco, Luigi Formisano, Nicholas Turner, Miguel Martin
CLINICAL CANCER RESEARCH (2023)
Impact of the 21-Gene Assay in Patients with High-Clinical Risk ER-Positive and HER2-Negative Early Breast Cancer: Results of the KARMA Dx Study
Antonio Llombart-Cussac, Antonio Anton-Torres, Beatriz Rojas, Raquel Andres, Noelia Martinez, Cesar A. Rodriguez, Sara Marin, Teresa Puertolas, Alejandro Falcon Gonzalez, Maria Leonor Fernandez-Murga, Carlos Hagen, Manuel Ruiz-Borrego
CANCERS (2023)
SEOM-GEICAM-SOLTI clinical guidelines for early-stage breast cancer (2022)
Francisco Ayala de la Pena, Silvia Antolin Novoa, Joaquin Gavila Gregori, Lucia Gonzalez Cortijo, Fernando Henao Carrasco, Maria Teresa Martinez Martinez, Cristina Morales Estevez, Agostina Stradella, Maria Jesus Vidal Losada, Eva Ciruelos
CLINICAL & TRANSLATIONAL ONCOLOGY (2023)